These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24394117)

  • 21. Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients.
    Bellino R; Cortese P; Danese S; De Sanctis C; Durando A; Genta F; Grio R; Giardina G; Katsaros D; Massobrio M; Richiardi G; Vicelli R
    Anticancer Res; 2000; 20(6C):4825-8. PubMed ID: 11205227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II open-label clinical study of comparing nab-paclitaxel with pemetrexed as second-line chemotherapy for patients with stage IIIB/IV non-small-cell lung cancer.
    Liu Z; Wei Z; Hu Y; Gao F; Hao L; Fang P; Sun S; Li J; Jiao S
    Med Oncol; 2015 Aug; 32(8):216. PubMed ID: 26168982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of giant advanced ulcerative breast cancer managed with epirubicin and cyclophosphamide followed by weekly paclitaxel].
    Moriya T; Fukatsu K; Ueda S; Iwaya K; Osaki A; Yamamoto J
    Gan To Kagaku Ryoho; 2010 May; 37(5):907-10. PubMed ID: 20495326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
    Hirsh V; Okamoto I; Hon JK; Page RD; Orsini J; Sakai H; Zhang H; Renschler MF; Socinski MA
    J Thorac Oncol; 2014 Jan; 9(1):83-90. PubMed ID: 24346096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer.
    Robidoux A; Buzdar AU; Quinaux E; Jacobs S; Rastogi P; Fourchotte V; Younan RJ; Pajon ER; Shalaby IA; Desai AM; Fehrenbacher L; Geyer CE; Mamounas EP; Wolmark N
    Clin Breast Cancer; 2010 Feb; 10(1):81-6. PubMed ID: 20133263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of nab-paclitaxel plus carboplatin in combination with thoracic radiation in patients with locally advanced non-small-cell lung cancer.
    Hasegawa T; Futamura Y; Horiba A; Yoshida T; Suzuki T; Kato T; Kaito D; Ohno Y; Iida T; Hayashi S; Sawa T
    J Radiat Res; 2016 Jan; 57(1):50-4. PubMed ID: 26442970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.
    Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M
    Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A Case Report of Surgery and Chemotherapy for a Patient with Rapidly Progressing Breast Cancer during Pregnancy].
    Hazama Y; Nakai Y; Sugawara S; Nomura T; Matsumoto K; Matsumoto R; Sugihara M; Ishida T; Murata S; Murata T; Nakamura T; Moriya T; Kurebayashi J; Shimoya K
    Gan To Kagaku Ryoho; 2018 May; 45(5):847-850. PubMed ID: 30026449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
    Shitara K; Takashima A; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Makari Y; Amagai K; Ueda S; Yoshida K; Shimodaira H; Nishina T; Tsuda M; Kurokawa Y; Tamura T; Sasaki Y; Morita S; Koizumi W
    Lancet Gastroenterol Hepatol; 2017 Apr; 2(4):277-287. PubMed ID: 28404157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Two Cases of Lung Stage ⅢSquamous Cell Carcinoma Treated with Carboplatin (CBDCA)plus Nab-Paclitaxel(Nab-PTX)].
    Yoshino Y; Miyagi J; Toume R; Naha Y; Uchihara T; Akamine M; Nakazato H; Kawakami M; Tomori T; Nagayoshi S; Nagamine S; Tomiyama T; Ohmine Y; Sasaki H; Ishikawa M; Maeshiro K
    Gan To Kagaku Ryoho; 2019 Jul; 46(7):1171-1173. PubMed ID: 31296824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility study of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected non-small-cell lung cancer: FAST-nab.
    Saji H; Marushima H; Miyazawa T; Sakai H; Kimura H; Kurimoto N; Nakamura H
    Anticancer Drugs; 2017 Aug; 28(7):795-800. PubMed ID: 28538017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral facial nerve palsy associated with amphiphysin antibody in metastatic breast cancer: a case report.
    Kwatra V; Charakidis M; Karanth NV
    J Med Case Rep; 2021 Mar; 15(1):158. PubMed ID: 33766120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer.
    Tanaka H; Taima K; Morimoto T; Tanaka Y; Itoga M; Nakamura K; Hayashi A; Kumagai M; Yasugahira H; Mikuniya M; Okudera K; Takanashi S; Tasaka S
    BMC Cancer; 2017 Oct; 17(1):683. PubMed ID: 29037236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A Case of Recurrent Breast Cancer with Carcinomatous Pleurisy Successfully Treated with Paclitaxel and Bevacizumab after Radical Mastectomy].
    Sakaguchi N; Moriya T; Yamazaki T; Yamagishi Y; Hasegawa S; Tsuda H; Hase K; Yamamoto J
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):751-3. PubMed ID: 26199251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of left breast cancer resulting in complete response by primary systemic therapy].
    Fukuda T; Watanabe T; Kawahara M; Kodama H; Kikuchi S; Suzuki H
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1497-500. PubMed ID: 17876155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.
    Moebus V; Jackisch C; Lueck HJ; du Bois A; Thomssen C; Kurbacher C; Kuhn W; Nitz U; Schneeweiss A; Huober J; Harbeck N; von Minckwitz G; Runnebaum IB; Hinke A; Kreienberg R; Konecny GE; Untch M
    J Clin Oncol; 2010 Jun; 28(17):2874-80. PubMed ID: 20458045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor dominant neuropathy induced by adjuvant therapy with adriamycin and cyclophosphamide followed by dose-dense paclitaxel in a breast cancer patient.
    Hikino H; Kawashima M; Yamada T; Ozaki N
    Int J Clin Oncol; 2006 Aug; 11(4):332-5. PubMed ID: 16937310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Complete Remission after Weekly Intravenous Nanoparticle Albumin-Bound Paclitaxel in Elderly Patients with Non-Small-Cell Lung Cancer].
    Sugiura Y; Hashizume T; Kawai O; Ohkubo Y; Fusegawa H; Araki N; Kaseda S; Nemoto E
    Gan To Kagaku Ryoho; 2015 Sep; 42(9):1095-7. PubMed ID: 26469167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of Paclitaxel-induced peripheral neuropathy successfully treated with duloxetine].
    Nagashima S; Kiba T; Ogawa Y; Mura T; Kajiume S; Okada Y; Morii N; Takahashi H; Ichiba Y; Yamashiro H
    Gan To Kagaku Ryoho; 2015 May; 42(5):617-9. PubMed ID: 25981658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301.
    Miyauchi E; Inoue A; Usui K; Sugawara S; Maemondo M; Saito H; Fujita Y; Kato T; Suzuki T; Harada T; Watanabe H; Nakagawa T; Ichinose M
    Oncologist; 2017 Jun; 22(6):640-e59. PubMed ID: 28526722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.